The Access Consortium comprises the medicine and healthcare regulatory agencies of Australia, Canada, the UK, Singapore and Switzerland. This updated strategic plan outlines the Consortium's approach to regulatory collaboration, streamlined processes and improved access to safe and effective medicines. Key objectives include encouraging joint applications and supporting regulatory innovation.

This consultation paper examines the issues around prescription opioid use and misuse in Australia and explores options for a regulatory response to issues identified.